Mealey's (February 27, 2017, 3:17 PM EST) -- GREENVILLE, Miss. — A Mississippi federal judge on Feb. 22 dismissed without prejudice most of a plaintiff’s Farxiga diabetic ketoacidosis (DKA) claims (Kamilah Young v. Bristol-Myers Squibb Company, et al., No. 16-108, N.D. Miss., Greenville Div., 2017 U.S. Dist. LEXIS 24730)....